MedPage Today - “Alzheimer's Meeting to Focus on Progress”

Boston, MA
 – July 12, 2013  –– 

Novel treatment approaches, new diagnostic and treatment-monitoring technologies, and recent findings on potentially modifiable risk factors for the disease were among the topics covered at the week-long Alzheimer's Association International Conference, July 14 – July 21. Sam Gandy, MD, PhD, an Alzheimer's disease specialist at the Icahn School of Medicine at Mount Sinai, said that he expected AAIC attendees would be talking about the FDA's recent draft guidance document detailing the agency's data demands for new Alzheimer therapies.
Learn more at Medpage Today